Evan L. Gilius

Cholecystokinin Receptor Antagonist Halts Progression of Pancreatic Cancer Precursor Lesions and Fibrosis in Mice

Jill P. Smith, Timothy K. Cooper, Christopher O. McGovern et al. · Pancreas · 2014 · 45 citations · Full text

Cholecystokinin Mediates Progression and Metastasis of Pancreatic Cancer Associated with Dietary Fat

Gail L. Matters, Timothy K. Cooper, Christopher O. McGovern et al. · Digestive Diseases and Sciences · 2014 · 37 citations · Full text

Pancreatic Cancer, Gastrointestinal Oncology, Medicine +11

PhotoImmunoNanoTherapy Reveals an Anticancer Role for Sphingosine Kinase 2 and Dihydrosphingosine-1-Phosphate

Brian M. Barth, Sriram S. Shanmugavelandy, James M. Kaiser et al. · ACS Nano · 2013 · 34 citations · Full text

Engineering, Immunology, Cell Death +17

Downregulation of the CCK-B receptor in pancreatic cancer cells blocks proliferation and promotes apoptosis

Kristin Fino, Gail L. Matters, Christopher O. McGovern et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2012 · 31 citations

Chemoprevention Strategy, Apoptosis, Immunology +19

A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancer

Jill P. Smith, John F. Harms, Gail L. Matters et al. · Cancer Biology & Therapy · 2012 · 19 citations · Full text

Single Nucleotide Polymorphism, Immunology, Genetic Epidemiology +17